Jesse Solomon is a partner in the Antitrust Practice Group and strategizes with clients and deal teams to secure U.S. and global competition clearances for complex transactions across sectors, including in life sciences, healthcare, media, and industrials. Jesse is recognized as a prominent antitrust practitioner by Chambers USA, The Legal 500 U.S., Lawdragon, and Global Competition Review. He was named a “Stand-Out Lawyer” by Thomson-Reuters and a “D.C. Rising Star” by the National Law Journal. Clients have recognized Jesse as “brilliant” and “thoughtful, instantly responsive, smart and creative in approaching complex issues.”
Jesse represents clients both in antitrust investigations of complex, high-profile transactions and in non-merger conduct investigations before the Federal Trade Commission and the U.S. Department of Justice. He has been the lead partner for clients in some of the largest and most challenging antitrust investigations in recent history.
A selection of Jesse’s prior representations includes:
Healthcare, Pharmaceuticals, and Chemicals
- Aetna on its $77 billion sale to CVS Health.
- CVS Caremark on its $1.25 billion acquisition of Universal American’s Medicare PDP business.
- PracticeTek on its merger with Integrated Practice Solutions.
- PJT Partners regarding Amgen’s $28.5 billion Horizon Therapeutics acquisition.
- Roche on its $4.8 billion acquisition of Spark Therapeutics.
- Shire on its $62 billion acquisition by Takeda.
- Syngenta on:
- its $43 billion acquisition by ChemChina;
- its successful defense of a $46.5 billion takeover proposal by Monsanto; and
- antitrust lawsuits by the FTC and numerous state attorneys general, and multiple civil class actions regarding the crop inputs industry and loyalty rebate programs.
- Warner Chilcott’s $8.5 billion acquisition by Actavis.
- Numerous other pharmaceutical and biotech companies in major global transactions.
Media & Technology
- Clarivate Analytics on its:
- its $5.3 billion acquisition of ProQuest;
- $6.8 billion combination with CPA Global; and
- $950 million acquisition of Decision Resources Group.
- ICM Partners on its acquisition of Creative Artists Agency following a lengthy DOJ review.
- Nuvei on its $1.3 billion acquisition of Paya Holdings.
- RTL Group on the sale of SpotX to Magnite.
- Uniti Group on the divestiture purchase of assets sold by CenturyLink in connection with its acquisition of Level 3.
- A major technology company in parallel investigations by the FTC, DOJ and nearly 50 states.
Industrial Businesses and Transportation
- Bridgepoint on the sale of DMC Power to Golden Gate Capital.
- Fibria on its $11 billion sale to Suzano.
- General Electric on numerous transactions selling GE Capital lending units.
- The Greenbrier Companies on its $400 million acquisition of American Railcar Industries.
- TRATON (formerly Volkswagen Truck & Bus) on its:
- $250 million joint venture with Navistar; and
- $3.7 billion acquisition of Navistar.
Consumer Products
- Campbell Soup on its $2.7 billion acquisition of Sovos Brands.
- ConAgra on the $2.7 billion sale of its private brands business to TreeHouseFoods.
- PepsiCo on the $3.3 billion sale of its Tropicana, Naked and other juice brand businesses to PAI Partners.
- Tyson Foods on its $8.55 billion acquisition of Hillshire Brands.
- A leading consumer products company on several acquisitions of beverage and nutrition businesses.
Financial and Consulting Services
- BATS Global Markets on its:
- $3.4 billion sale to CBOE Global Markets; and
- acquisition of Direct Edge.
- PricewaterhouseCoopers on its sale of its public sector government consulting practice.
